Filing Details
- Accession Number:
- 0001053369-13-000005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-14 19:12:19
- Reporting Period:
- 2013-01-11
- Filing Date:
- 2013-01-14
- Accepted Time:
- 2013-01-14 19:12:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1053369 | Elite Pharmaceuticals Inc | ELTP | Pharmaceutical Preparations (2834) | 223542636 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1465824 | Ram Potti | C/O Epic Pharma, Llc 227-15 North Conduit Avenue Laurelton NY 11413 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-01-11 | 2,339,000 | $0.09 | 7,220,635 | No | 4 | S | Indirect | see footnote |
Common Stock | Acquisiton | 2013-01-14 | 6,032,000 | $0.06 | 13,252,635 | No | 4 | M | Indirect | see footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | see footnote |
No | 4 | M | Indirect | see footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Disposition | 2013-01-14 | 6,032,000 | $0.06 | 6,032,000 | $0.06 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,103,332 | 2009-06-03 | 2016-06-03 | No | 4 | X | Indirect |
Footnotes
- Ram Potti is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer, and also serves as a director of the issuer
- Of the 7,220,635 shares of common stock, 6,989,002 shares of common stock are owned indirectly through EI and 231,633 shares are owned directly by the reporting person.
- Of the 13,252,635 shares of common stock, 13,021,002 shares of common stock are owned indirectly through EI and 231,633 shares are owned directly by the reporting person.